Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19 (2020)

First Author: Gaziano L

Attributed to: Aetiology of type 2 diabetes and related metabolic disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2020.11.19.20234120

Publication URI: http://dx.doi.org/10.1101/2020.11.19.20234120

Type: Preprint